XTLB
XTL Biopharmaceuticals
XTLB
XTLB
6 hedge funds and large institutions have $1.69M invested in XTL Biopharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$129K |
| 2 |
SW
2
SteelPeak Wealth
Woodland Hills,
California
|
$48K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$12K |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$180K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $662K | 198,888 | – | – |
|
|
NC
2
Noked Capital
Tel Aviv,
Israel
| $662K | 198,888 | – | – |
|
|
3
Morgan Stanley
New York
| $180K | 54,026 | -2,797 | -5% |
|
|
4
Renaissance Technologies
New York
| $129K | 38,800 | +19,269 | +99% |
|
|
SW
5
SteelPeak Wealth
Woodland Hills,
California
| $48K | 14,375 | +14,375 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $12K | 3,524 | +3,524 | New |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|